GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Poniard Pharmaecuticals, Inc. (PARD) [hlAlert]

Rating:
Mkt Outperform
PARD
down 99.67 %

Poniard Pharmaecuticals, Inc. (PARD) upgraded to Mkt Outperform with price target $2 by Rodman & Renshaw

Posted on: Tuesday,  Jun 8, 2010  11:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Poniard Pharmaecuticals, Inc. (OTCBB: PARD) on 06/08/2010, when the stock price was $36.76.
Since then, Poniard Pharmaecuticals, Inc. has lost 99.67% as of 08/27/2015's recent price of $0.12.
If you would have followed this Rodman & Renshaw's recommendation on PARD, you would have lost 99.67% of your investment in 1906 days.

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of cancer therapy products. Its lead product candidate is picoplatin, a platinum-based cancer therapy. An intravenous chemotherapeutic agent, picoplatin is designed to overcome platinum resistance in the treatment of solid tumors. The Company initiated a Phase III SPEAR (Study of Picoplatin Efficacy After Relapse) trial of picoplatin in small cell lung cancer. The Company is also conducting separate Phase I/II studies of picoplatin in the treatment of patients with metastatic colorectal cancer and hormone-refractory prostate cancer. NeoRx Manufacturing Group, Inc. is a wholly owned subsidiary of the Company.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/8/2010 11:25 AM Buy
None
36.76 80.00
as of 12/31/2010
1 Week up  18.51 %
1 Month up  77.77 %
3 Months up  10.34 %
1 YTD down  -30.35 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2009 8:25 AM Hold
None
77.20

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy